Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Robin

Showing results (121-130 of 298) with videos related to

Pageof 30
Sort By:
American Journal of Hematology|July 8, 2015
Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord bloodClémence Granier, Lucie Biard, Emeline Masson, et al.
Cell Death & Disease|September 29, 2023
Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysisMaxence Wisztorski, Soulaimane Aboulouard, Lucas Roussel, et al.
Bone Marrow Transplantation|May 25, 2024
Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigensAliénor Xhaard, Aline Floch, Mathilde Ruggiu, et al.
Nature Medicine|August 1, 2017
The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host diseaseJérôme Legoff, Matthieu Resche-Rigon, Jerome Bouquet, et al.
Leukemia|May 27, 2021
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working PartyDonal P McLornan, Juan Carlos Hernandez-Boluda, Tomasz Czerw, et al.
Vaccine|July 15, 2022
Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipientsAlexis Cuffel, Sarah Maylin, Helene Le Buanec, et al.
Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.
Transplantation|September 25, 2012
Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantationAnna D Petropoulou, Raphael Porcher, Regis Peffault de Latour, et al.
Bone Marrow Transplantation|June 27, 2020
Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantationSimona Pagliuca, Pedro Henrique Prata, Aliénor Xhaard, et al.
BMC Cancer|December 19, 2024
Preoperative versus postoperative radiotherapy for localized soft tissue sarcoma treated with curative intent in a French tertiary center "SARCLOC"Maxime Noeuveglise, Williams Tessier, Maël Barthoulot, et al.
Pageof 30

Showing results (121-130 of 298) with videos related to

Sort By:
Pageof 30
American Journal of Hematology|July 8, 2015
Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord bloodClémence Granier, Lucie Biard, Emeline Masson, et al.
Cell Death & Disease|September 29, 2023
Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysisMaxence Wisztorski, Soulaimane Aboulouard, Lucas Roussel, et al.
Bone Marrow Transplantation|May 25, 2024
Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigensAliénor Xhaard, Aline Floch, Mathilde Ruggiu, et al.
Nature Medicine|August 1, 2017
The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host diseaseJérôme Legoff, Matthieu Resche-Rigon, Jerome Bouquet, et al.
Leukemia|May 27, 2021
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working PartyDonal P McLornan, Juan Carlos Hernandez-Boluda, Tomasz Czerw, et al.
Vaccine|July 15, 2022
Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipientsAlexis Cuffel, Sarah Maylin, Helene Le Buanec, et al.
Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.
Transplantation|September 25, 2012
Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantationAnna D Petropoulou, Raphael Porcher, Regis Peffault de Latour, et al.
Bone Marrow Transplantation|June 27, 2020
Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantationSimona Pagliuca, Pedro Henrique Prata, Aliénor Xhaard, et al.
BMC Cancer|December 19, 2024
Preoperative versus postoperative radiotherapy for localized soft tissue sarcoma treated with curative intent in a French tertiary center "SARCLOC"Maxime Noeuveglise, Williams Tessier, Maël Barthoulot, et al.
Pageof 30